Clinical Trials Browser

Available × INDUSTRY × Myelodysplastic Syndromes × Clear all

NCT05593185 2024-12-09

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms